Clinical trial registry record

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 24, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06851988
Last registry update
September 24, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Chang Gung Memorial Hospital
Enrollment
290
Countries
Taiwan
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · OTHER · NONE
Evidence population
Human clinical study registration
Participants
290
Population
ALL · 20 Years to 80 Years
Duration
2023-05-03 to 2026-10-30
Intervention
HIIT & Record of physical activities at home.; HIIT only
Comparator
Head and Neck patient after CCRT treatment-Experimental group; Head and Neck patient after CCRT treatment-Validation group
Outcomes measured
percent of participants with phenoage and age — baseline before CCRT; percent of participants with phenoage and age — 1 months after the completion of CCRT; percent of participants with phenoage and age — 6 months after the completion of CCRT; percent of participants with phenoage and age — 9 months after the completion of CCRT; Peak VO2 (ml/min/kg) of participants — baseline before CCRT; Peak VO2 (ml/min/kg) of participants — 1 months after the completion of CCRT; Peak VO2 (ml/min/kg) of participants — 6 months after the completion of CCRT; Peak VO2 (ml/min/kg) of participants — 9 months after the completion of CCRT; Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled term: cancer. Abstract contains controlled term: cancer. Source terminology contains: cancer. Title supplies longevity context: senescence. Study type is explicitly identified as INTERVENTIONAL.
  • Exercise · 100%Title contains controlled term: exercise. Abstract contains controlled term: exercise. Title supplies longevity context: senescence. Study type is explicitly identified as INTERVENTIONAL.
  • Immune ageing · 80%Title contains controlled term: immunosenescence. Title supplies longevity context: senescence. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.